We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Panel: AEDs Should Stay Class III and Be Subject to the PMA Path
Panel: AEDs Should Stay Class III and Be Subject to the PMA Path
January 28, 2011
In a move that could cost devicemakers millions of dollars, an FDA advisory panel has backed the agency’s proposal to classify automated external defibrillators (AEDs) as Class III devices that must go through the PMA process.